Since the sample testing process includes classification, numbering, scanning into groups, centrifugation, lid removal, sample rack placement, storage on filing racks, and sending to the refrigerator, a single assembly line can typically complete 70-80% of the tasks in the laboratory. Therefore, error-prone processes can be fully automated through assembly lines. In recent years, automated laboratories have evolved from single-machine sales to modular assembly lines (MA mode), sample pretreatment systems (TTA mode), and then to full laboratory automation systems (TLA mode). These can automate and integrate certain operations or steps in the laboratory, reducing sample processing and testing time, improving testing efficiency, and lowering error rates. This full laboratory automation system (TLA mode) has strong scalability; business modules can be added according to sample volume. At the same time, the application of assembly lines can reduce error rates and improve testing efficiency, thus saving labor costs and operating expenses, while reducing biological hazards to human health.
The industrial chain of the microbiological testing industry includes upstream suppliers that provide chemical raw materials, auxiliary materials, active materials, and instrument materials. The midstream consists of manufacturers of microbiological testing reagents and equipment. The downstream market terminals include entities such as microbiological testing centers and medical institutions.
Among them, the upstream market,Chemical raw materials and auxiliary materials have weaker bargaining power in the midstream market due to their lower R&D difficulty, and most midstream manufacturers have extended their layout into related businesses. The quality of active materials has a significant impact on the midstream market, and due to R&D difficulties, the industry is still in its early stages, thus giving it a higher bargaining power over the midstream. Instrument materials span multiple fields, are technically challenging, and lack sufficient market competition, giving them stronger bargaining power over downstream suppliers.
For the midstream market,Due to the high quality and stability requirements for experimental instruments and reagents in downstream markets such as medical testing and scientific research, and the influence of factors such as development start-up time and technical barriers, most of China's microbiological testing manufacturers are currently monopolized by overseas manufacturers, which have stronger bargaining power.
